Outstanding shares: 79,187,836
Company also presenting at 11th Annual Conference on Carbon Capture Utilization & Sequestration
QUEBEC CITY, April 24, 2012 /CNW/ - CO2 Solutions Inc. (TSX-V: CST), an innovator in the field of
enzyme-enabled carbon capture technology, announced today that Glenn
Kelly, the Company's President and Chief Executive Officer, has been
selected to present at the Clean Tech Investor Conference at this
year's World Congress on Industrial Biotechnology & Bioprocessing.
Mr. Kelly will discuss recent progress related to the Company's carbon
capture technology program and its ability to reduce carbon pollution
from coal-fired power plants and other significant industrial sources
of CO2 emissions. The presentation will take place on Tuesday, May 1st at 11:30 am ET in Orlando, Florida.
At the same conference, on Wednesday, May 2nd, at 10:30 am ET, Jonathan Carley, Vice President, Business Development
of CO2 Solutions will participate in a presentation on the optimum performance
properties of enzymes in the context of CO2 capture.
The World Congress on Industrial Biotechnology and Bioprocessing is the
world's largest industrial biotechnology event for business leaders,
investors and policy makers in biofuels, biobased products, and
renewable chemicals. Entering its ninth year, the event will be held
April 29 to May 2 in Orlando, Florida and will bring together more than
1,000 attendees. More information can be found at www.bio.org/events/conferences/welcome-2012-bio-world-congress .
Webcasts for these two presentations will not be provided by the
conference sponsors. However, copies of CO2 Solutions' presentations will be posted on CO2 Solutions' website following the presentation dates.
On May 2nd, 2012, Dr. Sylvie Fradette, CO2 Solutions Inc. Vice President, Research & Development and Nathalie
Penders-van Elk, M.Sc. and PD. Eng., from CO2 Solutions collaboration partner, Procede Gas Treating, will be
presenting a poster at the 11th Annual Conference on Carbon Capture Utilization & Sequestration in
Pittsburgh, PA. The poster is entitled "The kinetics of absorption of carbon dioxide in aqueous amine and
carbonate solutions and carbonic anhydrase". Further details on this presentation and the conference can be found at www.carbonsq.com.
About CO2 Solutions Inc.
CO2 Solutions is an innovator in the field of enzyme-enabled carbon
capture and has been actively working to develop and commercialize the
technology for power plants and other large stationary sources of
carbon pollution. In the process, CO2 Solutions has built an extensive
patent portfolio covering the use of carbonic anhydrase, or analogues
thereof, for the efficient post‐combustion capture of carbon dioxide
with low‐energy aqueous solvents. Further information about CO2
Solutions can be found at www.co2solutions.com.
CO2 Solutions Forward-looking Statements
Certain statements in this news release may be forward-looking. These
statements relate to future events or CO2 Solutions' future economic performance and reflect the current
assumptions and expectations of management. Certain unknown factors may
affect the events, economic performance and results of operations
described herein. CO2 Solutions undertakes no obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as may be required under applicable
Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
SOURCE CO2 SOLUTIONS INC.
For further information:
Investor Relations and Media Contact:
418-842-3456, ext. 223
416-815-0700, ext. 225